NCT00878436View on ClinicalTrials.gov

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions
Prostate CancerProstatic Neoplasms
Interventions
DRUG

Panobinostat

DRUG

Bicalutamide

Trial Locations (4)

10016

NYU Cancer Center, New York

11042

North Shore University Hospital-Monter Cancer Center, Lake Success

97239

Oregon Health & Science University, Portland

08903

The Cancer Institute of New Jersey, New Brunswick

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

NYU Langone Health

OTHER